Furthermore, the GLP-1 analog exendin-4 reduced inflammation in a non-alcoholic steatohepatitis (NASH) animal model by decreasing the infiltration of macrophages (CD68+, F4/80+) [246]. The gene discussed is CD68; the disease is metabolic dysfunction-associated steatohepatitis.